Semi-quantitative analysis of the immunohistochemical staining and western blotting results showed a significant increase in the expression of p53-pS15 in keloids ( p = 0.0007, p = 0.002
When this system becomes disrupted through gut dysbiosis, inflammation, or insulin resistance the coordination of appetite control, fat storage, and glucose regulation begins to falter
Ozempic was originally developed for managing type 2 diabetes but has shown significant promise for weight management as well
Semaglutide is a GLP-1 receptor agonist used for chronic weight management alongside a reduced-calorie diet and increased physical activity for people with a BMI of: 30 kg/m or greater (obesity), or 27 kg/m or greater (overweight) with at least one weight-related condition (e.g., hypertension, type 2 diabetes, dyslipidemia)
The findings corroborated that oral semaglutide effectively reduces HbA1c levels and body weight, regardless of any other medications the patients might be on
.png)
